Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.
Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores
Dr. Bouzid Menaa
Patients today are seeking better health care, while healthcare providers and insurance companies are calling for cost-effective diagnosis and treatments. The biomedical industry thus faces the challenge of developing devices and materials that offer benefits to both patients and the healthcare industry. The combination of biology and nanotechnology, is expected to revolutionize biomedical research by exploiting novel phenomena and properties (physical chemical and biological) of material present at nanometer length (10-9m) scale and systems through control of matter on the nm scale and the direct application of nanomaterials to biological targets. Today, nanomaterials have been designed for a variety of biomedical and biotechnological applications, including biosensors, enzyme encapsulation; neuronal nanotechnology is based on the introduction of novel nano-materials which can result in revolutionary new structures and devices using extremely biological sophisticated tools to precisely position molecules. Carbon nanotubes (CNT) and functionalized fullerenes Bucky balls with bio-recognition properties provide tools at a scale, which offers a tremendous opportunity to study biochemical processes and to manipulate living cells at the single molecule level.